Related references
Note: Only part of the references are listed.Combining Biomarkers to Optimize Patient Treatment Recommendations
Chaeryon Kang et al.
BIOMETRICS (2014)
Optimization of individualized dynamic treatment regimes for recurrent diseases
Xuelin Huang et al.
STATISTICS IN MEDICINE (2014)
Q-LEARNING WITH CENSORED DATA
Yair Goldberg et al.
ANNALS OF STATISTICS (2012)
A Robust Method for Estimating Optimal Treatment Regimes
Baqun Zhang et al.
BIOMETRICS (2012)
Recursively Imputed Survival Trees
Ruoqing Zhu et al.
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2012)
Estimating Individualized Treatment Rules Using Outcome Weighted Learning
Yingqi Zhao et al.
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2012)
PERFORMANCE GUARANTEES FOR INDIVIDUALIZED TREATMENT RULES
Min Qian et al.
ANNALS OF STATISTICS (2011)
Reinforcement Learning Strategies for Clinical Trials in Nonsmall Cell Lung Cancer
Yufan Zhao et al.
BIOMETRICS (2011)
Reinforcement learning design for cancer clinical trials
Yufan Zhao et al.
STATISTICS IN MEDICINE (2009)
Demystifying optimal dynamic treatment regimes
Erica E. M. Moodie et al.
BIOMETRICS (2007)
Fast rates for support vector machines using gaussian kernels'
Ingo Steinwart et al.
ANNALS OF STATISTICS (2007)
Maximum likelihood estimation in semiparametric regression models with censored data
D. Zeng et al.
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY (2007)
Convexity, classification, and risk bounds
PL Bartlett et al.
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2006)
Multicategory support vector machines: Theory and application to the classification of microarray data and satellite radiance data
YK Lee et al.
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2004)
Optimal dynamic treatment regimes
SA Murphy
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY (2003)
Phase III trial comparing a defined duration of therapy versus continuous therapy followed by second-line therapy in advanced-stage IIIB/IV non-small-cell lung cancer
MA Socinski et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Selecting therapeutic strategies based on efficacy and death in multicourse clinical trials
PF Thall et al.
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2002)